Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients With Refractory Ascites
Clinical Drug Investigation- United Kingdom
doi 10.1007/s40261-018-0714-5
Full Text
Abstract
Available in
Date
October 4, 2018
Authors
Publisher
Springer Science and Business Media LLC